E1B 19K inhibits Fas-mediated apoptosis through FADD-dependent sequestration of FLICE

Journal of Cell Biology

Volumn 141, Issue 5, 1998, Pages 1255-1266

  Perez, Denise ^a   White, Eileen ^a,b,c  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; INTERLEUKIN 1BETA CONVERTING ENZYME; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; PROTEIN BCL 2; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; VIRUS PROTEIN;

ADENOVIRUS; APOPTOSIS; ARTICLE; CONTROLLED STUDY; HELA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOVIRUS E1B PROTEINS; ANTIGENS, CD95; APOPTOSIS; BCL-X PROTEIN; CARRIER PROTEINS; CASPASE 1; CYSTEINE ENDOPEPTIDASES; ENZYME ACTIVATION; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; HELA CELLS; HUMANS; MICROFILAMENTS; PROTO-ONCOGENE PROTEINS C-BCL-2;

ADENOVIRIDAE;

EID: 0032100771     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.141.5.1255     Document Type: Article

References (62)

1. Armstrong, R.C., T. Aja, J. Xioang, S. Gaur, J.F. Krebs, K. Hoang, X. Bai, S.J. Korsmeyer, D.S. Karanewsky, L.C. Fritz, and K.J. Tomaselli. 1996. Fas-induced activation of the cell death-related protease CPP32 is inhibited by Bcl-2 and by ICE family protease inhibitors. J. Biol. Chem. 27128:16850-16855.
2. Beidler, D.R., M. Tewari, P.D. Friesen, G. Poirier, and V.M. Dixit. 1995. The baculovirus p35 protein inhibits Fas- and tumor necrosis factor-induced apoptosis. J. Biol. Chem. 270:16526-16528.
3. Bellgrau, D., D. Gold, H. Selawry, J. Moore, A. Franzusoff, and R.C. Duke. 1995. A role for CD95 ligand in preventing graft rejection. Nature. 377:630-632.
4. L can inhibit apoptosis in cells that have undergone Fas-induced protease activation. Proc. Natl. Acad. Sci. USA. 94:3759-3764.
5. Boldin, M.P., E.E. Varfolomeev, Z. Pancer, I.L. Mett, J.H. Camonis, and D. Wallach. 1995. A novel protein that interacts with the death domain of Fas/ APO1 contains a sequence motif related to the death domain. J. Biol. Chem. 270:7795-7798.
6. Buldin, M.P., T.M. Goncharov, Y.V. Goltsev, and D. Wallach. 1996. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1-and TNF receptor-induced cell death. Cell. 85:803-815.
7. Cheng, E.H.-Y., D.G. Kirsch, R.J. Clem, F. Ravi, M.B. Kastan, A. Bedi, K. Ueno, and J.M. Hardwick. 1997. Conversion of Bcl-2 to a Bax-like death effector by caspases. Science. 278:1966-1968.
8. Chinnaiyan, A.M., K. O'Rourke, M. Tewari, and V.M. Dixit. 1995. FADD, a novel death domain-constraining protein, interacts with the death domain of Fas and initiates apoptosis. Cell. 81:505-512.
9. Chinnaiyan, A.M., K. Orth, K. O'Rourke, H. Duan, G.G. Poirier, and V.M. Dixit. 1996a. Molecular ordering of the cell death pathway. J. Biol. Chem. 271:4573-4576.
10. Chinnaiyan, A.M., C.G. Tepper, M.F. Seldin, K. O'Rourke, F.C. Kischkel, S. Hellbardt, P.M. Krammer, M.E. Peter, and V.M. Dixit. 1996b. FADD/ MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J. Biol. Chem. 271:4961-4965.
11. Chinnaiyan, A.M., D. Chaudhary, K. O'Rourke, E.V. Koonin, and V.M. Dixit. 1997a. Role of CED-4 in the activation of CED-3. Nature. 388:728-729.
12. Chinnaiyan, A.M., K. O'Rourke, B.R. Lane, and V.M. Dixit. 1997b. Interaction of CED-4 with CED-3 and CED-9: a molecular framework for cell death. Science 275:1122-1126.
13. Chiou, S.-K., L. Rao, and E. White. 1994a. Bcl-2 blocks p53-dependent apoptosis. Mol. Cell. Biol. 14:2556-2563.
14. Chiou, S.-K., C.C. Tseng, L. Rao, and E. White. 1994b. Functional complementation of the adenovirus E1B 19K protein with Bcl-2 in the inhibition of apoptosis in infected cells. J. Virol. 68: 6553-6566.
15. Clem, R.J., M. Fechheimer, and L.K. Miller. 1991. Prevention of apoptosis by a Baculovirus gene during infection of insect cells. Science. 254:1388-1390.
16. Debbas, M., and E. White. 1993. Wild-type p53 mediates apoptosis by E1A which is inhibited by E1B. Genes Dev. 7:546-554.
17. Enari, M., H. Hug, and S. Nagata. 1995. Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature. 375:78-81.
18. Foghsgaard, L., and M. Jäättelä. 1997. The ability of BHRF1 to inhibit apoptosis is dependent on stimulus and cell type. J. Virol. 171:7509-7571.
19. Gooding, L.R., L.W. Elmore, A.E. Tollefson, H.A. Brady, and W.S.M. Wold. 1988. A 14,700 MW protein from the E3 region of adenovirus inhibits cytolysis by tumor necrosis factor. Cell. 53:341-346.
20. Gooding, L.R., L. Aquino, P.J. Duerksen-Hughes, D. Day, T.M. Horton, S. Yei, and W.S.M. Wold. 1991a. The E1B-19K protein of group C adenoviruses prevents cytolysis by tumor necrosis factor of human cells but not mouse cells. J. Virol. 65:3083-3094.
21. Gooding, L.R., R. Ranheim, A.E. Tollefson, L. Aquino, P. Duerksen-Hughes, T.M. Horton, and W.S.M. Wold. 1991b. The 10,400-and 14,500-dalton proteins encoded by region E3 of adenovirus function together to protect many but not all mouse cell lines against lysis by tumor necrosis factor. J. Virol. 65: 4114-4123.
22. Griffith, T.S., T. Brunner, S.M. Fletcher, D.R. Green, and T.A. Ferguson. 1995. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science. 270:1189-1192.
23. Hahne, M., D. Rimoldi, M. Schröter, P. Romero, M. Schreier, L.E. French, P. Schneider, T. Bornand, A. Fontana, D. Lienard, et al. 1996. Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape. Science. 274:1363-1366.
24. Han, J., P. Sabbatini, D. Perez, L. Rao, D. Mohda, and E. White. 1996a. The E1B 19K protein blocks apoptosis by interacting with and inhibiting the p53-inducible and death-promoting Bax protein. Genes Dev. 10:461-477.
25. Han, J., P. Sabbatini, and E. White. 1996b. Induction of apoptosis by human Nbk/Bik, a BH3 containing E1B 19K interacting protein. Mol. Cell. Biol. 16: 5857-5864.
26. Hashimoto, S., A. Ishii, and S. Yonehara. 1991. The E1B oncogene of adenovirus confers cellular resistance to cytotoxicity of tumor necrosis factor and monoclonal anti-Fas antibody. Int. Immunol 3:343-351.
27. Henderson, S., D. Huen, M. Rowe, C. Dawson, G. Johnson, and A. Rickinson. 1993. Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. Proc. Natl. Acad. Sci. USA. 90:8479-8483.
28. Hengartner, M.O. 1996. Programmed cell death in invertebrates. Curr. Opin. Genet. Dev. 6:34-38.
29. Hsu, H., H.-B. Shu, M.G. Pan, and D.V. Goeddel. 1996. TRADD-TRAF2 and TRADD-FADD interaction define two distinct TNF receptor 1 signal transduction pathways. Cell. 84:299-308.
30. Hu, S., C. Vincenz, M. Buller, and V.M. Dixit. 1997. A novel family of viral death effector domain-containing molecules that inhibit both CD-95-and tumor necrosis factor receptor-1-induced apoptosis. J. Biol. Chem. 272:9621-9624.
31. Itoh, N., S. Yonehara, A. Ishii, M. Yonehara, S. Mizushima, M. Sameshima, A. Hase, Y. Seto, and S. Nagata. 1991. The polypeptides encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell. 66:233-243.
32. Kischkel, F.C., S. Hellbardt, I. Behrmann, M. Germer, M. Pawlita, P.H. Krammer, and M.E. Peter. 1995. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO (Eur. Mol. Biol. Organ.) J. 14:5579-5588.
33. Klinkert, W.E., K. Kojima, W. Lesslauer, W. Rinner, H. Lassmann, and H. Wekerle. 1997. TNF-α receptor fusion protein prevents experimental autoimmune encephalomyelitis and demyelination in Lewis rats: an overview. J. Neuroimmunol. 72:163-168.
34. Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:680-685.
35. Laster, S.M., J.G. Good, and L.R. Gooding. 1988. Tumor necrosis factor can induced both apoptic and necrotic forms of cell lysis. J. Immunol. 141:2629-2634.
36. Merino, R., D.A. Grillot, P.L. Simonian, S. Muthukkumar, W.C. Fanslow, S. Bondada, and G. Nunez. 1995. Modulation of anti-IgM-induced B cell apoptosis by Bcl-xL and CD40 in WEHI-231 cells. Dissociation from cell cycle arrest and dependence on the avidity of the antibody-IgM receptor interaction. J Immunol. 155:3830-3838.
37. Miura, M., H. Zhu, R. Rotello, E.A. Hartwieg, and J. Yuan. 1993. Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell. 75:653-660.
38. Miura, M., R.M. Friedlander, and J. Yuan. 1995. Tumor necrosis factor-induced apoptosis is mediated by a CrmA-sensitive cell death pathway. Proc. Natl. Acad. Sci. USA. 92:8318-8322.
39. Moran, E. 1993. DNA tumor virus transforming proteins and the cell cycle. Cur. Opin. Gen. Dev. 3:63-70.
40. Muzio, M., A.M. Chinnaiyan, F.C. Kischkel, K. O'Rourke, A. Shevchenko, J. Ni, C. Scaffidi, J.D. Bretz, M. Zhang, R. Gentz, M. Mann, P.H. Krammer, M.E. Peter, and V.M. Dixit. 1996. FLICE, a novel FADD-homologous ICE/ CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell. 85:817-827.
41. Muzio, M., G.S. Salvesen, and V.M. Dixit. 1997. FLICE-induced apoptosis in a cell-free system. J. Biol. Chem. 272:2952-2956.
42. Muzio, M., B.R. Stockwell, H.R. Stennicke, G.S. Salvesen, and V.M. Dixit. 1998. An induced proximity model for caspase-8 activation. J. Biol. Chem. 273:2926-2930.
43. Nagata, S. 1997. Apoptosis by death factor. Cell. 88:355-365.
44. Probert, L., K. Akassoglou, G. Kassiotis, M. Pasparakis, L. Alexopoulou, and G. Kollias. 1997. TNF-a transgenic and knockout models of CNS inflammation and degeneration. J. Neuroimmunol. 72:137-141.
45. Rao, L., M. Debbas, P. Sabbatini, D. Hockenberry, S. Korsmeyer, and E. White. 1992. The adenovirus E1A proteins induce apoptosis which is inhibited by the E1B 19K and Bcl-2 proteins. Proc. Natl. Acad. Sci. USA. 89:7742-7746.
46. Ray, C.A., R.A. Black, S.R. Kronheim, T.A. Greenstreet, P.R. Sleath, G.S. Salvesen, and D.J. Pickup. 1992. Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1β converting enzyme. Cell. 69: 597-604.
47. Sabbatini, P., J.H. Han, S.-K. Chiou, D. Nicholson, and E. White. 1997. Interleukin 1β converting enzyme-like proteases are essential for p53-mediated transcriptionally dependent apoptosis. Cell Growth Diff. 8:643-653.
48. L protects cancer cells from p53-mediated apoptosis. Oncogene. 11:1389-1394.
49. Seshagiri, S., and L.K. Miller. 1997. Caenorhabditis elegans CED-4 stimulates CED-3 processing and CED-3-induced apoptosis. Curr. Biol. 7:455-460.
50. Shisler, J., C. Yang, B. Walter, C.F. Ware, and L.R. Gooding. 1997. The adenovirus E3-10.4K/14.5K complex mediates loss of cell surface Fas (CD95) and resistance to Fas-induced apoptosis. J. Virol. 71:8299-8306.
51. Spector, M.S., S. Desnoyers, D.J. Hoeppner, and M.O. Hengartner. 1997. Interaction between the C. elegans cell-death regulators CED-9 and CED-4. Nature. 385:653-656.
52. Tewari, M., and V.M. Dixit. 1995. Fas-and TNF-induced apoptosis is inhibited by the poxvirus crmA gene product. J. Biol. Chem. 270:3255-3260.
53. Thome, M., P. Schneider, K. Hofmann, H. Fickenscher, E. Meinl, F. Neipel, C. Mattmann, K. Burns, J.-L. Bodmer, M. Schröter, C. Scaffidl, P.H. Krammer, M.E. Peter, and J. Tschopp. 1997. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature. 386:517-521.
54. Thompson, C.B. 1995. Apoptosis in the pathogenesis and treatment of disease. Science. 267:1456-1462.
55. White, E. 1996. Life, death, and the pursuit of apoptosis. Genes Dev. 10:1-15.
56. White, E., and R. Cipriani. 1989. Specific disruption of intermediate filaments and the nuclear lamina by the 19-kDa product of the adenovirus E1B oncogene. Proc. Natl. Acad. Sci. USA. 86:9886-9890.
57. White, E., and R. Cipriani. 1990. Role of adenovirus E1B proteins in transformation: altered organization of intermediate filaments in transformed cells that express the 19-kilodalton protein. Mol. Cell. Biol. 10:120-130.
58. White, E., S.H. Blose, and B. Stillman. 1984. Nuclear envelope localization of an adenovirus tumor antigen maintains the integrity of cellular DNA. Mol. Cell. Biol. 4:2865-2875.
59. White, E., R. Cipriani, P. Sabbatini, and A. Denton. 1991. The adenovirus E1B 19-kilodalton protein overcomes the cytotoxicity of E1A proteins. J. Virol. 65:2968-2978.
60. White, E., P. Sabbatini, M. Debbas, W.S.M. Wold, D.I. Kusher, and L. Gooding. 1992. The 19-kilodalton adenovirus E1B transforming protein inhibits programmed cell death and prevents cytolysis by tumor necrosis factor a. Mol. Cell. Biol. 12:2570-2580.
61. Wu, D., H.D. Wallen, and G. Nuñez. 1997. Interaction and regulation of subcellular localization of CED-4 by CED-9. Science. 275:1126-1128.
62. Yuan, J., S. Shaham, S. Ledoux, H.M. Ellis, and H.R. Horvitz. 1993. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme. Cell. 75:641-652.